Recreational Drug Use Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-and Active-Controlled Crossover Study to Evaluate the Intranasal Abuse Potential of PF614 Compared With Immediate-Release Oxycodone and Placebo in Non-Dependent Recreational Opioid Users
The purpose of this study is to examine the abuse potential and pharmacokinetics of PF614 compared with a non-abuse deterrent, commercially available, immediate release (IR) oxycodone hydrochloride (HCl) formulation and placebo.
This will be a randomized, double-blind, placebo-and active-controlled, 3-way crossover study to evaluate the abuse potential and pharmacokinetics of intranasally administered PF614, relative to crushed oxycodone HCl IR tablets and placebo in non-dependent recreational opioid users. The study will consist of 4 phases: Screening, Qualification, Treatment, and Follow-up. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03286218 -
A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
|
Phase 1 | |
| Completed |
NCT05571345 -
A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users
|
Phase 1 | |
| Recruiting |
NCT05031832 -
Chemsex Engagement and HIV Biomedical Prevention in MSM
|